ribociclib
novartis
['bcsm', ' ribo']
 two important parts of practice changing study 1 stage iia pts include n0 disease grade 2 w/high-risk characteristic ki-67 is 20% or higher oncotype score of at least 26
2 ribocicib dose 400 mg 600mg (metastatic disease less neutropenia #bcsm #asco23 
🎗Oncologist|🧬Cancer Researcher|President Ky @ASCO|MedSchool Professor @UofL|Faculty @ASCO @NCCN @OncoAlert|Advisor @MedScape @Onclive @Doximity|#MedTwitter